Results 21 to 30 of about 143,950 (267)

Designing adverse event forms for real-world reporting: participatory research in Uganda. [PDF]

open access: yes, 2012
The wide-scale roll-out of artemisinin combination therapies (ACTs) for the treatment of malaria should be accompanied by continued surveillance of their safety.
Clare I R Chandler   +37 more
core   +1 more source

Cutaneous adverse drug reactions in patients with peripheral blood eosinophilia during antituberculosis treatment [PDF]

open access: yesThe Korean Journal of Internal Medicine, 2019
Background/Aims Peripheral eosinophilia during tuberculosis (TB) treatment is common, but has not been fully evaluated. The aim of this study was to determine the prevalence and clinical significance of peripheral blood eosinophilia in patients ...
Tae-Ok Kim   +5 more
doaj   +1 more source

Cutaneous Adverse Events of Targeted Therapies and Immune-Checkpoint Inhibitors in Patients with Melanoma

open access: yesRevista da Sociedade Portuguesa de Dermatologia e Venereologia, 2021
Targeted therapy and immunotherapy have markedly improved prognosis of advanced melanoma patients. With expanded use of these drugs, a range of cutaneous adverse events has emerged.
Rita Pimenta   +4 more
doaj   +1 more source

A comparison between two recommendations to conduct and report systematic reviews on drug’s safety

open access: yesSystematic Reviews, 2019
Background Several recommendations are available to conduct and report a systematic review of adverse drug reactions. This study is aimed at identifying and comparing the methodologies of the two most commonly used recommendations to conduct and report ...
Ana Penedones   +2 more
doaj   +1 more source

Development and pilot study of “Smart Cancer Care”: a platform for managing side effects of chemotherapy

open access: yesBMC Health Services Research, 2023
Background As outpatient chemotherapy treatment increases, cancer patients receiving chemotherapy spend more time at home. In addition, since the types of chemotherapy are gradually expanding, it will be essential to prepare patient self-management ...
Cheolkyung Sin   +4 more
doaj   +1 more source

Torsadogenic risk of antipsychotics : combining adverse event reports with drug utilization data across Europe [PDF]

open access: yes, 2013
Antipsychotics (APs) have been associated with risk of torsade de Pointes (TdP). This has important public health implications. Therefore, (a) we exploited the public FDA Adverse Event Reporting System (FAERS) to characterize their torsadogenic profile; (
Barbui, Corrado   +62 more
core   +1 more source

Acute renal and neurotoxicity due to weight-based dosing of intravenous acyclovir: How to dose in obese patients?

open access: yesClinical Infection in Practice, 2020
Background: Acyclovir is a hydrophilic drug that is mainly distributed in the lean compartments of the body. Consequently, dosing on total body weight in obese patients may lead to drug overdosing.
Bastiaan TGM Sallevelt   +4 more
doaj   +1 more source

Short-term glucocorticoid-related side effects and adverse reactions: a narrative review and practical approach

open access: yes, 2022
Glucocorticoids are the mainstay treatment of a variety of inflammatory and autoimmune disorders. Unfortunately, metabolic side effects, drug interactions and adverse reactions commonly lead to glucocorticoid-related side effects, thereby compromising ...
Jörg D. Seebach   +7 more
core   +1 more source

Self-Initiation of Antiretroviral Therapy in the Developing World: the Involvement of Private Pharmacies in an HIV Program. [PDF]

open access: yes, 2012
Self-initiation to antiretroviral treatment (ART) exposes the patient to the risk of drug toxicity, poor adherence to treatment, and escalates the development of drug resistance.
Buma, Deus   +8 more
core   +1 more source

Uncommon progression of toxoplasmic papillitis: patient perception and case report

open access: yesRevista Brasileira de Oftalmologia, 2021
Ocular toxoplasmosis frequently presents as necrotizing retinochoroiditis and, less often, as peripapillary chorioretinitis and/or papillitis. The progression from papillitis to peripapillary retinochoroiditis has been rarely described.
Elcio Luiz Bonamigo   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy